STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7
Clinical trials for STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted pill after lung cancer surgery shows promise in extending life
Disease control OngoingThis study tests whether taking erlotinib (a daily pill that blocks cancer growth signals) after surgery helps people with a specific type of lung cancer (EGFR-mutant) live longer compared to just watching and waiting. About 390 adults with early-stage lung cancer that was fully …
Matched conditions: STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 11, 2026 12:08 UTC
-
Immunotherapy after lung cancer surgery shows promise in preventing recurrence
Disease control OngoingThis study tests whether adding the immunotherapy drug nivolumab after surgery and chemotherapy can help keep non-small cell lung cancer from coming back in patients with stage IB to IIIA disease. About 900 participants who had their lung cancer completely removed are randomly as…
Matched conditions: STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 08, 2026 13:04 UTC
-
Massive lung cancer study aims to match patients with precision treatments
Knowledge-focused OngoingThis study screens up to 8300 people with early-stage non-small cell lung cancer (stages IB to IIIA) whose tumor has been or will be removed by surgery. Researchers analyze the tumor's genes to find specific mutations, which helps doctors choose the most effective targeted therap…
Matched conditions: STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7
Phase: NA • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 17, 2026 03:11 UTC